civic enjoyer(@bimekizumab) 's Twitter Profile Photo

kurwa nie moge z tego ze nas nagrywali jednak jak spiewalismy pod kebabem XDDDD panie szefunciu od kebaba dziękujemy za dobrą zabawę

account_circle
Azahar Sancho(@AzaharSancho) 's Twitter Profile Photo

Ayer en
What’s 🆕?

✍🏻en Reumatología:
✅ Tocilizumab biosimilar
✅ Bimekizumab - EspA (💶 en estudio)
✅ Anifrolumab - LES
✅ Voclosporina - nefritis lúpica
✅ Avacopan - vasculitis ANCA+

Ayer en #FarmaIMID2023… 
What’s 🆕? 

✍🏻en Reumatología: 
✅ Tocilizumab biosimilar 
✅ Bimekizumab - EspA (💶 en estudio)
✅ Anifrolumab - LES 
✅ Voclosporina - nefritis lúpica 
✅ Avacopan - vasculitis ANCA+
account_circle
ASAS(@Official_ASAS) 's Twitter Profile Photo

Recent additions to the ASAS slide library: summaries of bimekizumab (anti IL-17A and IL-17F biologic) trials,
BE MOBILE 1 and BE MOBILE 2, in non-radiographic & radiographic axial SpA

See more slides here: asas-group.org/education/asas…

Recent additions to the ASAS slide library: summaries of bimekizumab (anti IL-17A and IL-17F biologic) trials, 
BE MOBILE 1 and BE MOBILE 2, in non-radiographic & radiographic axial SpA 

See more slides here: asas-group.org/education/asas…
account_circle
Mónica Delgado(@Monica_DelSan) 's Twitter Profile Photo

Excelente revisión de Emma sobre Uveitis 👁 y EsPA en
Recomendaciones EULAR y SER EsPA y APs ➡️ valorar antiTNF monoclonal si AP de Uveitis
Bimekizumab ➡️ no aumenta la tasa de Uveitis ➡️ futuro
Anti-JAK ➡️ futuro

Excelente revisión de @emma_beltran sobre Uveitis 👁 y EsPA en #SER2024 
Recomendaciones EULAR y SER EsPA y APs ➡️ valorar antiTNF monoclonal si AP de Uveitis
Bimekizumab ➡️ no aumenta la tasa de Uveitis ➡️ futuro 
Anti-JAK ➡️ futuro
account_circle
Meera Shah(@27Meera) 's Twitter Profile Photo

Year in review


-Brepocitinib: TYK2/JAKi found to be effective in PsA phase 2b study

- For treatment naive PsA
Joints: Bimekizumab= adalimumab
Skin: Bimekizumab > adalimumab

Year in review
#ACR23

-Brepocitinib: TYK2/JAKi found to be effective in PsA phase 2b study 

- For treatment naive PsA
Joints: Bimekizumab= adalimumab
Skin: Bimekizumab > adalimumab
account_circle
Eric Dein(@ericdeinmd) 's Twitter Profile Photo

Dr. John Cush
April Armstrong, MD MPH
Bimekizumab: IL-17A and IL-17F dual efficacy, unlike the prior IL-17i drugs
- Fast onset
- High efficacy with 2/3 PASI 100 by wk 16 (BE READY)

#RNL2024 @RheumNow 
@_AprilArmstrong 
Bimekizumab: IL-17A and IL-17F dual efficacy, unlike the prior IL-17i drugs
- Fast onset
- High efficacy with 2/3 PASI 100 by wk 16 (BE READY)
account_circle
JAMA Dermatology(@JAMADerm) 's Twitter Profile Photo

Findings of this case series suggest bimekizumab may be effective for treating PPP, palmoplantar plaque psoriasis with pustules, and SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome. ja.ma/4167Axl

Findings of this case series suggest bimekizumab may be effective for treating PPP, palmoplantar plaque psoriasis with pustules, and SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome. ja.ma/4167Axl #JDP2023
account_circle
Bull Bear Bres|nahan(@BullBearBres) 's Twitter Profile Photo

$UCB.BB
🇧🇪
UCB

First presentation of four-year BIMZELX® (bimekizumab-bkzx) data showed long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis

mb.cision.com/Public/18595/3…

cc: $TUB.BB 🇧🇪 Tubize

$UCB.BB
🇧🇪
UCB

First presentation of four-year BIMZELX® (bimekizumab-bkzx) data showed long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis

mb.cision.com/Public/18595/3…

cc: $TUB.BB 🇧🇪 Tubize
account_circle